These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 9796411)
1. [Tumor angiogenesis]. Ono M; Kuwano M Seikagaku; 1998 Sep; 70(9):1159-70. PubMed ID: 9796411 [No Abstract] [Full Text] [Related]
2. Science, medicine, and the future. Antivascular therapy: a new approach to cancer treatment. Hayes AJ; Li LY; Lippman ME BMJ; 1999 Mar; 318(7187):853-6. PubMed ID: 10092266 [No Abstract] [Full Text] [Related]
3. [Vascular growth and non-small cell lung cancer]. Fan X; Guo X; Han B Zhonghua Jie He He Hu Xi Za Zhi; 2001 Aug; 24(8):499-502. PubMed ID: 11718044 [No Abstract] [Full Text] [Related]
4. [Opening to the age of regenerative medicine--the mechanism of angiogenesis]. Murota S Kokubyo Gakkai Zasshi; 2002 Jun; 69(2):81-8. PubMed ID: 12136664 [No Abstract] [Full Text] [Related]
5. [Research on the endothelium and new therapeutic strategies in tumors and cardiovascular diseases]. Dejana E Recenti Prog Med; 1999 Feb; 90(2):64-8. PubMed ID: 10208094 [No Abstract] [Full Text] [Related]
6. Cancer experts offer healthy dose of skepticism toward hype over antiangiogenesis agents. Phillips P JAMA; 1998 Jun; 279(24):1936-7. PubMed ID: 9643843 [No Abstract] [Full Text] [Related]
7. [Antiangiogenic therapy]. Toi M Gan To Kagaku Ryoho; 1998 Nov; 25(13):2003-9. PubMed ID: 9838900 [TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of tumor angiogenesis and tumor progression. Cavallaro U; Christofori G J Neurooncol; 2000; 50(1-2):63-70. PubMed ID: 11245282 [TBL] [Abstract][Full Text] [Related]
11. [Tumor dormancy therapy for hepatocellular carcinoma]. Hori T; Ido A; Tsubouchi H Nihon Rinsho; 2001 Oct; 59 Suppl 6():824-8. PubMed ID: 11762064 [No Abstract] [Full Text] [Related]
12. Are angiostatin and endostatin cures for cancer? Harris AL Lancet; 1998 May; 351(9116):1598-9. PubMed ID: 9620709 [No Abstract] [Full Text] [Related]
13. Inhibitors of angiogenesis enter phase III testing. Nelson NJ J Natl Cancer Inst; 1998 Jul; 90(13):960-3. PubMed ID: 9665141 [No Abstract] [Full Text] [Related]
14. Inhibitors of angiogenesis in a clinical perspective. Voest EE Anticancer Drugs; 1996 Sep; 7(7):723-7. PubMed ID: 8949981 [TBL] [Abstract][Full Text] [Related]
15. Angiogenesis in cancer, vascular, rheumatoid and other disease. Folkman J Nat Med; 1995 Jan; 1(1):27-31. PubMed ID: 7584949 [TBL] [Abstract][Full Text] [Related]
16. Regulating angiogenesis: a new therapeutic strategy. Gibaldi M J Clin Pharmacol; 1998 Oct; 38(10):898-903. PubMed ID: 9807969 [TBL] [Abstract][Full Text] [Related]
17. Angiogenesis: the unifying concept in cancer? Saphir A J Natl Cancer Inst; 1997 Nov; 89(22):1658-9. PubMed ID: 9390530 [No Abstract] [Full Text] [Related]
18. Cancer 'cure' article stirs up hot debate. Wadman M Nature; 1998 May; 393(6681):104-5. PubMed ID: 9603508 [No Abstract] [Full Text] [Related]
19. Angiogenesis: is it the key to controlling the healing process? Neal MS J Wound Care; 2001 Jul; 10(7):281-7. PubMed ID: 12964349 [No Abstract] [Full Text] [Related]
20. The role of vascular cell integrins alpha v beta 3 and alpha v beta 5 in angiogenesis. Varner JA EXS; 1997; 79():361-90. PubMed ID: 9002227 [No Abstract] [Full Text] [Related] [Next] [New Search]